Bruce A. Chabner, M.D.
|Title||Professor of Medicine|
|Institution||Massachusetts General Hospital|
|Address||Massachusetts General Hospital|
100 Blossom Street
Boston MA 02114
Available: 07/01/12, Expires: 07/01/13
Examine the impact of patient selection, based on molecular profiling of patient's tumor, on the success of new drug development in cancer. The ability to select patients for early clinical trials, based on molecularly profiling tumors, has greatly expedited drug evaluation in recent studies at the Harvard Hospitals. The impact of this change in strategy on the time to approval of cancer drugs will be the subject of this study.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.